Thermo Fisher Scientific, announced an expansion of their strategic partnership with Sanofi to enable additional U.S. drug product manufacturing. The terms of the deal were not disclosed. Under the agreement, Thermo Fisher will acquire Sanofi’s steriles manufacturing site in Ridgefield, New Jersey and will continue t…
10x Genomics, Inc., a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore (A*STAR GIS), announced a research collaboration for the Target Inference from Spatialomics & Histology Using Multimodal AI & Phenotypes (TISHUMAP) project. This initiative will leverage 10x Genomics' …
Astellas Pharma Inc.announced that it has agreed on a memorandum of understanding (“MoU”) with the Korea Institute of Startup and Entrepreneurship Development (President: Jong-pil Yoo, “KISED”), an umbrella organization of the Ministry of SMEs and Startups, a Korean Government Agency, for the operation of the Partner…
Sorcero, a leader in AI-powered analytics for life sciences companies, announced its acquisition of Axiom Health, a real-world data platform focused on the medical technology industry. The Axiom Health platform becomes Sorcero MedTech, enabling the Sorcero Intelligence Platform to become the first unified AI platform …
Almac Clinical Services, part of the Almac Group, has completed a multi-million-pound investment to enhance cold chain capabilities at its global headquarters in Craigavon, Northern Ireland. This strategic investment includes the completion of a purpose-built Ultra-Low Temperature facility which has tripled Almac Cli…
Veeda Lifesciences, a global contract research organization (CRO), has announced an investment in Mango Sciences, a Boston-based healthcare AI and data company. Through this investment, Veeda intends to leverage AI capabilities to enhance the speed, efficiency, and quality of Clinical Trials services across its expand…
XtalPi, a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced an expansion of its research collaboration with Pfizer to pioneer a next-generation molecular modeling platform for drug discover…
HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and autoimmune diseases, announces the signing of a major out-licensing agreement with Shanghai Henlius Biotech, Inc. (hereafter "Henlius"). The deal grants Henlius exclusive development and commercializat…
llumina, Inc. announced it has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-…
BioNTech SE and CureVac N.V. announced that they have entered into a definitive Purchase Agreement pursuant to which BioNTech intends to acquire all of the shares of CureVac, a clinical-stage biotech company developing a novel class of transformative medicines in oncology and infectious diseases based on messenger ri…
Page 34 of 39